Conditional approval in the European Union could be secured in the second half of December, he added. "If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively," he said. COVID-19 RUNS RAMPANTThe final trial analysis comes a week after initial results showed the vaccine was more than 90% effective. Global shares rose as the trial results countered concerns around the stubbornly high global infection rate. Moderna and Johnson & Johnson have said they hope to start testing the vaccine in younger patients soon.

Source: Mint November 19, 2020 00:33 UTC